Public and private partnerships in healthcare

The Indian pharmaceutical industry, which is expected to touch $130 billion by 2030, is the largest provider of generic medicines globally. India, known as ‘pharmacy to the world’, is the source of 60,000 generic brands across 60 therapeutic categories and home to 3,000 pharma companies with a network of more than 10,500 manufacturing facilities. Yet, the healthcare sector faces several challenges. The challenges include skyrocketing out-of-pocket expenditure, spurious medications and regulatory loopholes.In the latest series of The Medicine Box, top executives of the Organisation of Pharmaceutical Producers of India (OPPI) speak on a range of topics related to the pharma and healthcare industry.The podcast, hosted by CNBC-TV18’s Ekta Batra, and in association with OPPI, which represents research-based pharmaceutical companies in India, has six episodes. The third episode features N Rajaram, Board Member OPPI and managing director of Sanofi India. He discusses public-private partnerships in healthcare and shares vital insights on how one can deliver better health outcomes.​ Tune in!

The podcast, hosted by CNBC-TV18’s Ekta Batra, and in association with OPPI, which represents research-based pharmaceutical companies in India, has six episodes. The third episode features N Rajaram, Boar Member OPPI and managing director of Sanofi India. He discusses public-private partnerships in healthcare and shares vital insights on how one can deliver better health outcomes. Tune in!